Bridgefront Capital, LLC Nevro Corp Transaction History

Bridgefront Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.56 - $20.78 $144,576 - $221,556	10,662 New	10,662 $153,000
Q1 2022 May 13, 2022	SELL	$59.95 - $92.06 $157,248 - $241,473	-2,623 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$81.07 - $121.29 $212,646 - $318,143	2,623 New	2,623 $213,000
Q2 2021 Aug 12, 2021	SELL	$141.6 - $179.06 $282,208 - $356,866	-1,993 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$132.81 - $182.18 $264,690 - $363,084	1,993 New	1,993 $278,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.